These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37920207)

  • 1. Applying machine learning algorithms to develop a survival prediction model for lung adenocarcinoma based on genes related to fatty acid metabolism.
    Cong D; Zhao Y; Zhang W; Li J; Bai Y
    Front Pharmacol; 2023; 14():1260742. PubMed ID: 37920207
    [No Abstract]   [Full Text] [Related]  

  • 2. Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction.
    Li X; Lei J; Shi Y; Peng Z; Gong M; Shu X
    Curr Med Chem; 2024; 31(17):2449-2466. PubMed ID: 37961859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m7G-Associated subtypes, tumor microenvironment, and validation of prognostic signature in lung adenocarcinoma.
    Wang G; Zhao M; Li J; Li G; Zheng F; Xu G; Hong X
    Front Genet; 2022; 13():954840. PubMed ID: 36046251
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of a fatty acid metabolism-related gene signature to predict prognosis in stomach adenocarcinoma.
    Liu L; Sun J; Zhong C; Zhang A; Wang G; Chen S; Zhang S; Wang M; Li L
    Aging (Albany NY); 2024 May; 16(10):8552-8571. PubMed ID: 38742949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of natural killer cell associated subtyping and gene signature to predict prognosis and drug sensitivity of lung adenocarcinoma.
    Zhang D; Zhao Y
    Front Genet; 2023; 14():1156230. PubMed ID: 37091780
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.
    Shu J; Jiang J; Zhao G
    Front Immunol; 2023; 14():1177847. PubMed ID: 37583701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular subtype construction and prognosis model for stomach adenocarcinoma characterized by metabolism-related genes.
    Sun J; Wang Y; Zhang K; Shi S; Gao X; Jia X; Cong B; Zheng C
    Heliyon; 2024 Apr; 10(7):e28413. PubMed ID: 38596054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Analysis and Identification of Molecular Subtypes of TRP-Related Genes and Prognosis Prediction in Lung Adenocarcinoma.
    Guo Y; Liu N
    J Oncol; 2022; 2022():5388283. PubMed ID: 36090899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of lung adenocarcinoma classification and risk model based on necroptosis-related genes.
    Wu G; Feng D; Zhang Z; Zhang G; Zhang W
    Front Genet; 2022; 13():1037011. PubMed ID: 36452156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prognostic model established using bile acid genes to predict the immunity and survival of patients with gastrointestinal cancer.
    Wu X; Liu P; Wang Q; Sun L; Wang Y
    Environ Toxicol; 2024 Apr; ():. PubMed ID: 38606991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
    Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinoma.
    Tang X; Qi C; Zhou H; Liu Y
    Heliyon; 2022 Aug; 8(8):e10164. PubMed ID: 36016532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma.
    Lv Y; Xiao Y; Cui X; Luo H; Xu L
    Front Genet; 2022; 13():1016871. PubMed ID: 36313444
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification and Verification of Metabolism-related Immunotherapy Features and Prognosis in Lung Adenocarcinoma.
    Luo J; An J; Jia R; Liu C; Zhang Y
    Curr Med Chem; 2024 Mar; ():. PubMed ID: 38500277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment tool based on fatty acid metabolic signatures for predicting the prognosis and treatment response in bladder cancer.
    Chen X; Zhang Z; Liao W; Zhao Y
    Heliyon; 2023 Dec; 9(12):e22768. PubMed ID: 38076064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Typing Based on Oxidative Stress Genes and Establishment of Prognostic Characteristics of 7 Genes in Lung Adenocarcinoma.
    Tu J; Tang M; Li G; Chen L; Huang Y
    Oxid Med Cell Longev; 2022; 2022():9683819. PubMed ID: 36148413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-related molecular subtypes in lung adenocarcinoma identify novel tumor microenvironment with prognostic and therapeutic implications.
    Wen H; Chen H; Xie L; Li Z; Zhang Q; Tian Q
    Front Genet; 2022; 13():1012164. PubMed ID: 36263430
    [No Abstract]   [Full Text] [Related]  

  • 18. An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma.
    Zhang M; Zhu K; Pu H; Wang Z; Zhao H; Zhang J; Wang Y
    Front Oncol; 2019; 9():1314. PubMed ID: 31921619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a prognostic risk assessment model for lung adenocarcinoma based on Integrin β family-related genes.
    Wu Y; Fu L; Wang B; Li Z; Wei D; Wang H; Zhang C; Ma Z; Zhu T; Yu G
    J Clin Lab Anal; 2022 Jun; 36(6):e24419. PubMed ID: 35403268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of Lung Adenocarcinoma Based on Immune Checkpoint and Screening of Related Genes.
    Zhou T; Yang P; Tang S; Zhu Z; Li X; Yang Z; Wu R; Tian X; Li L
    J Oncol; 2021; 2021():5512325. PubMed ID: 34367284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.